97 related articles for article (PubMed ID: 22994085)
21. Circulating TNFRI and TNFRII levels correlated with the disease activity score (DAS28) in rheumatoid arthritis.
Valle Y; Ledezma-Lozano IY; Torres-Carrillo N; Padilla-Gutiérrez JR; Navarro-Hernández RE; Vázquez-Del Mercado M; Palafox-Sánchez CA; Armendáriz-Borunda J; Muñoz-Valle JF
Scand J Rheumatol; 2009; 38(5):332-5. PubMed ID: 19579138
[TBL] [Abstract][Full Text] [Related]
22. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
[TBL] [Abstract][Full Text] [Related]
23. [Serum tumor necrosis factor alpha (TNF-alpha) concentration correlates with soluble adhesion molecules and vascular endothelial growth factor (VEGF) in rheumatoid arthritis].
Klimiuk PA; Sierakowski S; Fiedorczyk M; Chwiećko J
Przegl Lek; 2004; 61(2):86-9. PubMed ID: 15230147
[TBL] [Abstract][Full Text] [Related]
24. [Serum soluble adhesion molecules--sICAM-1, sVCAM-1, sE-selectin--in patients with systemic rheumatoid arthritis].
Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
Pol Merkur Lekarski; 2004 Oct; 17(100):353-6. PubMed ID: 15690700
[TBL] [Abstract][Full Text] [Related]
25. [Markers of endothelial dysfunction (VCAM-1 and vWF) in chronic hepatitis C].
Antonova TV; Romanova MA; Lymar' IuV
Ter Arkh; 2013; 85(12):86-9. PubMed ID: 24640675
[TBL] [Abstract][Full Text] [Related]
26. [Clinical associations of C-reactive protein in systemic sclerosis].
Alekperov RT; Baranov AA; Abaĭtova NE
Ter Arkh; 2006; 78(6):30-5. PubMed ID: 16881360
[TBL] [Abstract][Full Text] [Related]
27. Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients.
Hjeltnes G; Hollan I; Førre Ø; Wiik A; Mikkelsen K; Agewall S
Scand J Rheumatol; 2011 Nov; 40(6):422-7. PubMed ID: 22150462
[TBL] [Abstract][Full Text] [Related]
28. Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment.
Lal P; Su Z; Holweg CT; Silverman GJ; Schwartzman S; Kelman A; Read S; Spaniolo G; Monroe JG; Behrens TW; Townsend MJ
Arthritis Rheum; 2011 Dec; 63(12):3681-91. PubMed ID: 22127691
[TBL] [Abstract][Full Text] [Related]
29. Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis.
Xiangyang Z; Lutian Y; Lin Z; Liping X; Hui S; Jing L
Cytokine; 2012 Apr; 58(1):6-9. PubMed ID: 22239947
[TBL] [Abstract][Full Text] [Related]
30. Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis.
Syngle A; Vohra K; Kaur L; Sharma S
Scand J Rheumatol; 2009; 38(1):15-22. PubMed ID: 18766955
[TBL] [Abstract][Full Text] [Related]
31. Roles of claudin-5 and von Willebrand factor in patients with rheumatoid arthritis.
Gurol G; Ciftci IH; Harman H; Karakece E; Kamanli A; Tekeoglu I
Int J Clin Exp Pathol; 2015; 8(2):1979-84. PubMed ID: 25973092
[TBL] [Abstract][Full Text] [Related]
32. Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort.
Gottenberg JE; Dayer JM; Lukas C; Ducot B; Chiocchia G; Cantagrel A; Saraux A; Roux-Lombard P; Mariette X
Ann Rheum Dis; 2012 Jul; 71(7):1243-8. PubMed ID: 22532637
[TBL] [Abstract][Full Text] [Related]
33. Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis.
Wållberg-Jonsson S; Caidahl K; Klintland N; Nyberg G; Rantapää-Dahlqvist S
Scand J Rheumatol; 2008; 37(1):1-5. PubMed ID: 18189187
[TBL] [Abstract][Full Text] [Related]
34. Oral glucose tolerance test effects on endothelial inflammation markers in healthy subjects and diabetic patients.
Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Fogari E; Gravina A; Mereu R; Palumbo I; Maffioli P; Randazzo S; Cicero AF
Horm Metab Res; 2010 Jan; 42(1):8-13. PubMed ID: 19735057
[TBL] [Abstract][Full Text] [Related]
35. P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis.
Ertenli I; Kiraz S; Arici M; Haznedaroglu IC; Calgüneri M; Celik I; Kirazli S
J Rheumatol; 1998 Jun; 25(6):1054-8. PubMed ID: 9632062
[TBL] [Abstract][Full Text] [Related]
36. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function.
Nelson CL; Karschimkus CS; Dragicevic G; Packham DK; Wilson AM; O'Neal D; Becker GJ; Best JD; Jenkins AJ
Nephrol Dial Transplant; 2005 Nov; 20(11):2420-6. PubMed ID: 16115854
[TBL] [Abstract][Full Text] [Related]
37. von Willebrand factor and endothelial damage in essential hypertension.
Blann AD; Naqvi T; Waite M; McCollum CN
J Hum Hypertens; 1993 Apr; 7(2):107-11. PubMed ID: 8510081
[TBL] [Abstract][Full Text] [Related]
38. Possible evidence of endothelial cell activation and disturbance in thalassemia: an in vitro study.
Butthep P; Bunyaratvej A; Funahara Y; Kitaguchi H; Fucharoen S; Sato S; Bhamarapravati N
Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():141-148A. PubMed ID: 9640617
[TBL] [Abstract][Full Text] [Related]
39. Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis.
Tikiz C; Utuk O; Pirildar T; Bayturan O; Bayindir P; Taneli F; Tikiz H; Tuzun C
J Rheumatol; 2005 Nov; 32(11):2095-101. PubMed ID: 16265685
[TBL] [Abstract][Full Text] [Related]
40. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction.
Jezovnik MK; Poredos P
Int Angiol; 2010 Jun; 29(3):226-31. PubMed ID: 20502419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
